Home LiteratureArticle Details
PMID: 2554337 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.

Wessels MR, Rubens CE, Benedí VJ, Kasper DL

Abstract

Sialylation of bacterial capsules has been proposed as an important virulence factor for several species of encapsulated pathogens, including group B Streptococcus. We have constructed a transposon mutant strain of type III group B Streptococcus that expresses a capsular polysaccharide differing from the wild type only in that the mutant strain's capsule lacks sialic acid. The mutant polysaccharide is antigenically identical to the capsular polysaccharide of type 14 Streptococcus pneumoniae, as predicted by the structures of the type III group B Streptococcus and S. pneumoniae polysaccharides. Loss of capsular sialic acid was associated with loss of virulence in the mutant strain in a neonatal rat model of lethal group B Streptococcus infection. These studies demonstrate directly that capsular sialic acid is a critical virulence determinant for type III group B Streptococcus and support the general hypothesis that surface sialylation aids pathogenic microorganisms in evading host defenses.

MeSH Terms
Bacterial Toxins/genetics DNA Transposable Elements Enzyme-Linked Immunosorbent Assay Fluorescent Antibody Technique Immunoblotting Immunodiffusion Microscopy, Electron Mutation Nucleic Acid Hybridization Plasmids Polysaccharides, Bacterial/genetics Sialic Acids/analysis Streptococcus agalactiae/genetics,pathogenicity,ultrastructure Virulence
Chemicals
Bacterial Toxins DNA Transposable Elements Polysaccharides, Bacterial Sialic Acids streptococcal polysaccharide type III group B
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Wessels M R
Channing Laboratory, Brigham and Women's Hospital, Boston, MA 02115.
Rubens C E
Benedí V J
Kasper D L
References (17)
17 references, click to expand
  1. Cell adhesion and the molecular processes of morphogenesis.
    Annu Rev Biochem. 1985;54:135-69 PMID: 3896119
  2. Regeneration of insertionally inactivated streptococcal DNA fragments after excision of transposon Tn916 in Escherichia coli: strategy for targeting and cloning of genes from gram-positive bacteria.
    J Bacteriol. 1984 Jul;159(1):214-21 PMID: 6330031
  3. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.
    Proc Natl Acad Sci U S A. 1987 Oct;84(20):7208-12 PMID: 2823254
  4. The thiobarbituric acid assay of sialic acids.
    J Biol Chem. 1959 Aug;234(8):1971-5 PMID: 13672998
  5. Bacterial meningitis: newer concepts of pathophysiology and neurologic sequelae.
    Pediatr Clin North Am. 1976 Aug;23(3):541-56 PMID: 785352
  6. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.
    J Mol Biol. 1977 Jun 15;113(1):237-51 PMID: 881736
  7. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
    Proc Natl Acad Sci U S A. 1978 Apr;75(4):1971-5 PMID: 273923
  8. Electron microscopic definition of surface antigens of group B Streptococcus.
    J Infect Dis. 1979 Feb;139(2):147-51 PMID: 374641
  9. ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes.
    J Immunol Methods. 1979;28(1-2):187-92 PMID: 38284
  10. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.
    Infect Immun. 1979 Aug;25(2):603-9 PMID: 385502
  11. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.
    J Exp Med. 1980 May 1;151(5):1275-87 PMID: 6989947
  12. Lysis and protoplast formation of group B streptococci by mutanolysin.
    Infect Immun. 1980 Jun;28(3):1033-7 PMID: 6995317
  13. Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide.
    Biochemistry. 1981 Aug 4;20(16):4511-8 PMID: 6170311
  14. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
    J Immunol. 1982 Mar;128(3):1278-83 PMID: 7035562
  15. Age-dependent susceptibility of neonatal rats to group B streptococcal type III infection: correlation of severity of infection and response of myeloid pools.
    Infect Immun. 1982 Jul;37(1):255-63 PMID: 7107007
  16. Biosynthesis of cell wall peptidoglycan and polysaccharide antigens by protoplasts of type III group B Streptococcus.
    J Bacteriol. 1983 Apr;154(1):211-20 PMID: 6339471
  17. Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen.
    J Biol Chem. 1987 Jun 15;262(17):8262-7 PMID: 3298228
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1989-11-00
Pages
8983-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC298416
Subset
IM
Grants
NIAID NIH HHS · AI22498 · United States
NIAID NIH HHS · AI23339 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]